Hôpital de la Pitié-Salpêtrière
Hôpital de la Pitié-Salpêtrière
Paris, France6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Phase 3 | 2026-08-28 | NCT05999604 | |
| Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, sarcoidosis | Active, not recruiting | Phase 3 | 2026-04-24 | NCT05689879 | |
| ALS Diagnosis From a Saliva Sample: a Non-coding RNA Analysis Approach | Amyotrophic Lateral Sclerosis, Sporadic, Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, amyotrophic lateral sclerosis type 1, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Active, not recruiting | Not stated | 2026-03-27 | NCT05928416 | |
| Social-cognitive Functioning: Validation of a New Neuropsychological Test | Alzheimer disease, Lewy body dementia, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy, tauopathy | Recruiting | Not applicable | 2026-03-13 | NCT05558709 | |
| Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial. | Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Phase 3 | 2026-01-21 | NCT06342544 | |
| DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2023-04-07 | NCT04920617 |